InsidersTradesSigma
Lixte Biotechnology Holdings, INC.: directors' dealings · United States · SEC (Form 4)
SEC:lixte-biotechnology-holdings-inc-8e1100US·SEC (Form 4)Mcap 57M€Healthcare
Explore the full management transaction log of Lixte Biotechnology Holdings, INC., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Lixte Biotechnology Holdings, INC. has recorded 1 public disclosures. Market capitalisation: €57.2m. The latest transaction was filed on 6 April 2022 — Retenue fiscale. Among the most active insiders: FORMAN ERIC. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Analyst consensus
Valuation
P/Book5.5x
Beta1.05
Balance sheet & cash
Market cap57.2 M€
Debt / Equity9%
Profitability & ownership
ROE-102.0%
ROA-46.0%
% insiders4.5%
% institutions6.9%
Last declaration on 6 April 2022
Declarations1 total
Executives●Retenue fiscale8SEC
01,333,333 shares0
Common Stock
SEC:0001493152-22-009303:0·
1 of 1 declaration